| |
|
 |
In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.
Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.
Main Business Structure of Zhongheng Group, 2006
Market Pattern of Drugs Used in Hospitals, 2006
|
|
|
|
|
If this report could not still meet your requirement, or
you have any comments or suggestions on it, please leave a
message to us.
|
2005-2007 www.researchinchina.com All Rights Reserved
| |
|
|
| |
|
In 2006, the company received the main business revenue of RMB 321.1685 million, of which the pharmaceutical industry accounted for 62.83%; the profit of main business reached RMB 154.1201 million and, the net profit amounted to RMB 19.6635 million.
Xueshuantong Freeze-Dry Powder for Injection, the company's core pharmaceutical product, is an important variety in cardiovascular and cerebrovascular fields. At present, the company's full-loaded monthly production capacity can not meet the increased market demand, so some products are contracted to Chongqing Yaoyou Pharmaceutical temporarily. It is estimated that the sales volume of Xueshuantong Freeze-Dry Powder for Injection will be 25 million doses in 2007, and 40 million in 2008, 50 million in 2009.
Main Business Structure of Zhongheng Group, 2006
Market Pattern of Drugs Used in Hospitals, 2006
|
|
|
|
|
2005-2006 www.researchinchina.com All Rights Reserved |
|
| |
|
 |
| |
|
1 Company profile
1.1 Equity rights transferred by SASAC
1.2 Strategies of the company
1.3 Management and marketing of the company2. Analysis on cardiovascular drugs
2.1 Analysis on the market
2.2 Traditional Chinese medicine in cardiovascular field
2.3 Market status of the company's Xueshuantong (Freeze-Dry) Powder for Injection 3. Development of the company
3.1 Patent
3.2 Development of the company's pharmaceutical business in 2007
3.3 Status quo of the company's new base
|
|
|
|
|
2005-2006 www.researchinchina.com All Rights Reserved |
|
| |
|
 |
| |
|
Equity structure of the company
Main business structure of Zhongheng Group, 2006
Market pattern of drugs used in hospitals, 2006
Variation in medicine sales income of Zhongheng Group
Parts of financial indicators of Zhongheng Group
Share and growth rate of sub-classified cardiovascular drugs, 2006
Classification of cardiovascular drugs and main varieties
Comparison of main traditional Chinese injection varieties
Patent application for main inventions of Guangxi Wuzhou Pharmaceuticals (Group) Co., Ltd
|
2005-2008 www.researchinchina.com All Rights Reserved
|
